About Alimera Sciences (ALIM)
Alimera Sciences, Inc. is a commercial-stage global pharmaceutical company. The Company is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for no... Read more
- USD5.55
- USD5.63
- USD5.54
- USD5.65
- 0.20%
- 100M
- 9.09M
- 973.27k
- 301M
- 2.61
- 72.10%
- 173.80%
Stock News
2 hours ago
Kenvue Inc. (KVUE): Short Sellers Are Buying This Beauty Stock
Yahoo
yesterday
Is Nvidia Really as Popular as You Think? 1 Number That Has Me Concerned About the Company's Long-Term Prospects.
Yahoo
yesterday
Up 12% in 2024, You May Want to Buy This Semiconductor Stock Before It Goes on a Bull Run
Yahoo
yesterday
Is NVR, Inc.'s (NYSE:NVR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
